ArticleAntibodies (Basel, Switzerland)2025

In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting.

Gloria Krapež et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.